Skip to content

Assessing the additional benefit of an innovative imaging system for colonoscopy

Assessing the additional neoplasia yield of FUll Spectrum Endoscopy in a CRC screening setting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN10357435
Enrollment
700
Registered
2015-09-18
Start date
2014-09-01
Completion date
Unknown
Last updated
2019-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Colorectal cancer 2. Colorectal adenomas Cancer 1. Colorectal cancer 2. Colorectal adenomas

Interventions

Patients are randomly allocated into two groups, who will each undergo a colonoscopy. For patients in the first group, a standard white light HD endoscope (Standard Forward View) is used, and for pati

Sponsors

CPO Piemonte
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consecutive patients aged 50 to 69 years undergoing their first colonoscopy examination in the participating centers following a positive fecal immunochemical test (FIT) performed in the context of a regional mass-screening program.

Exclusion criteria

Exclusion criteria: 1. Personal history of colorectal cancer or advanced adenoma 2. More than one first degree relative with colorectal cancer 3. Inflammatory bowel disease (IBD) 4. Endoscopy within past 5 years

Design outcomes

Primary

MeasureTime frame
1. Additional yield of advanced adenomas in patients when using Fuse as compared to SFV 2. Proportion of patients detected with 3 or more adenomas when using Fuse as compared to SFV

Secondary

MeasureTime frame
1. Overall adenoma and polyp detection rate, flat adenoma and serrated polyps/adenomas detection rate of the two techniques, determined from the information recorded in endoscopist and pathology reports 2. Comparison of the size of multiple lesions detected by the two methods, determined from the information recorded in endoscopist and pathology reports 3. Comparison of the detection rate of neoplasia by colonic site: distal (rectum, sigmoid and descending colon) and proximal (proximal to the descending colon), determined from the information recorded in endoscopist and pathology reports 4. Differences in the surveillance guidelines post-colonoscopy when comparing the two arms, determined from the information recorded in endoscopist and pathology reports 5. Comparison of the time required to reach the cecum, determined from the information recorded in endoscopist and pathology reports 6. Comparison of the withdrawal and total procedure time, determined from the information recorded in endoscopist and pathology reports 7. Assessing the learning curve of participating endoscopists, determined from the information recorded in endoscopist and pathology reports 8. Assessing patient’s experience, measured using a questionnaire administered at the end of the examination 9. Assessing the specific contribution of the additional view estimating the proportion of polyps detected using the additional views only, determined from the information recorded in endoscopist and pathology reports

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 5, 2026